Skip to content
Search

Latest Stories

AstraZeneca expects to supply 2m doses of Covid-19 vaccine every week in UK

ABOUT two million doses of Covid-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January in the UK, The Times reported.

AstraZeneca expects to supply two million doses of the vaccine in total by next week, the newspaper reported, citing an unnamed member of the Oxford-AstraZeneca team. "The plan is then to build it up fairly rapidly - by the third week of January we should get to two million a week," the report added.


The company was not immediately available to respond to a Reuters request for comment.

The report comes after Britain on Wednesday(30) approved the Oxford-AstraZeneca Covid-19 vaccine, hoping that rapid action will help it stem a record surge of infections driven by a highly contagious form of the virus.

Prime minister Boris Johnson has ordered 100 million doses for the country as part of an agreement with the company. The company had said it aims to supply millions of doses in the first quarter, adding that first vaccinations are slated to begin this year.

Britain, which has recorded more than 50,000 new daily cases of Covid-19 for the last four days, is dealing with a rapid spread of a much more infectious variant of the coronavirus. As of Friday, the UK has recorded 53,285 new Covid-19 cases and 613 deaths.

More For You

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
Toblerone dark chocolate discontinued in the UK, confirms Mondelez

This reflects both the popularity of the product and the frustration of fans

iStock

Toblerone dark chocolate discontinued in the UK, confirms Mondelez

Toblerone fans in the UK will no longer be able to purchase the dark chocolate version of the iconic Swiss chocolate bar, as manufacturer Mondelez has confirmed it has discontinued the product.

The company stated that it has made the “difficult decision” to stop production of the 360g Toblerone Dark bar. While no specific reason was given, Mondelez acknowledged the disappointment it may cause among consumers. A spokesperson said: “While we understand that this may be disappointing for some consumers, we continue to invest in Toblerone.”

Keep ReadingShow less
Crispello Comeback: Cadbury’s Light Treat Hits B&M Shelves

The return to UK shelves has brought a wave of nostalgia for many

Getty

Cadbury Crispello chocolate bars return to UK shelves at B&M for 49p

Cadbury's Crispello chocolate bars have made a surprise return to UK stores, now available at B&M for just 49p. The product, a mix of light wafer and smooth chocolate, had previously been discontinued in the UK and was only available overseas in recent years.

Each individual pack of Crispello contains four chocolate-covered wafer fingers, filled with a creamy chocolate centre. The sweet treat has gained attention on social media, with shoppers expressing their excitement about its reappearance in British stores.

Keep ReadingShow less
 Sharon Osbourne

Celebrities including Sharon Osbourne and Oprah Winfrey might be exhibiting signs of this side effect

Instagram/ Sharonosbourne

‘Ozempic feet’ joins growing list of unusual side effects linked to popular weight-loss drug

Ozempic, the blockbuster weight-loss medication that has surged in popularity across the United States and among celebrities, is now being linked to a new and unexpected side effect like sagging skin on the feet, informally dubbed “Ozempic feet”.

Medical experts say the condition is caused by rapid fat loss, which not only alters the appearance of the face and buttocks, but can also lead to aesthetic changes in the feet. As the drug continues to make headlines for its weight-loss benefits, concerns about such side effects are also gaining attention.

Keep ReadingShow less